Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and carbapenems

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with carbapenems in 1 studies

Compound Research Comparison

Studies
(1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid)
Trials
(1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid)
Recent Studies (post-2010)
(1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid)
Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010) (carbapenems)
792164767,3551475,277

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arvidsson, PI; Bester, LA; Chonco, L; Essack, SY; Govender, T; Kruger, HG; Naicker, T; Parboosing, R; Somboro, AM; Tiwari, D1

Other Studies

1 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and carbapenems

ArticleYear
NOTA: a potent metallo-β-lactamase inhibitor.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Escherichia coli; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure

2015